1. Home
  2. CAR vs UTHR Comparison

CAR vs UTHR Comparison

Compare CAR & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

HOLD

Current Price

$204.74

Market Cap

25.2B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$564.66

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAR
UTHR
Founded
1946
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.2B
25.1B
IPO Year
1998
1999

Fundamental Metrics

Financial Performance
Metric
CAR
UTHR
Price
$204.74
$564.66
Analyst Decision
Sell
Buy
Analyst Count
7
14
Target Price
$136.57
$567.57
AVG Volume (30 Days)
5.2M
526.3K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
50.71
13.07
EPS
N/A
27.86
Revenue
$11,652,000,000.00
$1,483,300,000.00
Revenue This Year
$2.10
$6.39
Revenue Next Year
$1.81
$14.18
P/E Ratio
N/A
$20.53
Revenue Growth
N/A
2.38
52 Week Low
$85.96
$272.18
52 Week High
$847.70
$607.89

Technical Indicators

Market Signals
Indicator
CAR
UTHR
Relative Strength Index (RSI) 43.30 52.65
Support Level $126.54 $464.92
Resistance Level N/A $607.89
Average True Range (ATR) 112.69 13.13
MACD -15.48 -3.28
Stochastic Oscillator 0.09 23.72

Price Performance

Historical Comparison
CAR
UTHR

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: